First-in-Human Trial of Oral AN2-502998

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
First-in-Human Phase 1, Single-Center, Randomized, Blinded, Placebo-Controlled Trial in Healthy Adults to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Oral AN2-502998
Epistemonikos ID: d237605e46b3d3e93e2cb9fd87b9a96a9aab031c
First added on: Jun 18, 2025